WylieDavidHosmerMD

Oncology • Southington, CT

Physician

Join to view full profile

Dr. Hosmer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Hosmer's full profile

Already have an account?

Office
55 Meriden Ave Ste 1a
Southington, CT 06489
Phone+1 860-621-9316

Fax+1 860-620-5526

Education & Training

UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 2007 - 2010
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 2004 - 2007
Columbia University Vagelos College of Physicians and SurgeonsClass of 2004

Certifications & Licensure

CA State Medical License 2006 - Present
CT State Medical License 2010 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2012-2013

Clinical Trials

Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches Start of enrollment: 2014 Nov 01
Completed
Phase 2
Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer Start of enrollment: 2014 Sep 01
Completed
Phase 2, Phase 3
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers Start of enrollment: 2015 Dec 29
Active, not recruiting
Phase 3

Publications & Presentations

PubMed

Brief Report: Impact of Anti-Cancer Treatments on Outcomes of COVID-19 in Patients With Thoracic Cancers: A CCC19 Registry Analysis.
Amit A Kulkarni, Cassandra Hennessy, Grace Wilson, Vidhyalakshmi Ramesh, Clara Hwang
Clinical Lung Cancer. 2024-07-01
6 citations
Immunotherapy-associated complete heart block in a patient with NSCLC: A case report and literature review.
Alexander Vartanov, Aditi Kalotra, Jasmine Varughese, Shovendra Gautam, Sean M. Kandel
Respiratory Medicine Case Reports. 2021-01-01
83 citations
Dichloroacetate should be considered with platinum-based chemotherapy in hypoxic tumors rather than as a single agent in advanced non-small cell lung cancer.
Edward B. Garon, Heather R. Christofk, Wylie Hosmer, Carolyn D. Britten, Agnes Bahng
Journal of Cancer Research and Clinical Oncology. 2014-01-18

Press Mentions

Cardio-Oncology Program Receives Gold Standard CertificationJuly 21st, 2022
Woman Diagnosed with Rare Form of Breast Cancer at 23April 8th, 2016